chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report has been received from a Health Professional concerning a 7 year old, male subject, who had been receiving nasal FLUMIST. FLUMIST started on an unknown date. It was reported, that the patient was sneezing. He was sneezing after receiving the FMQ dose which started on 14-SEP-2013. The outcome of the event sneezing is unknown and the patient recovered from the event of sneezing after receiving the FMQ dose on an unspecified date. The report was considered to be non-serious by the reporter. Corrected report 27-SEP-2013. Sneezing added as adverse event, case was not suppressed.
No symptomatic adverse events were reported / No additional AE; Product was administered to patient following the temperature excursion; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender.  The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported.  On 20-APR-2023, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 ml, once (lot number W004648 was verified to be valid, expiration date reported and confirmed as 06-OCT-2024), administered as prophylaxis (route of administration and anatomical location were not provided). The vaccine was administered to the patient following a temperature excursion of 34.4 degree Fahrenheit (F), for a time frame of 15 hours 0 minutes 0 seconds, and did not suffered previous temperature excursion (Product storage error).  No symptomatic adverse events (AEs) were reported. No additional information at that time. ; Sender's Comments:  US-009507513-2306USA010406: US-009507513-2306USA010676:
Pt recvd 1st dose of vax in 16APR92 & 2 days later pt exp nausea, dry heaves & vomited 3 to 4 times;
pt recvd vax;w/in 10 hrs devel T 102 w/ v;loose stool;red,sore eyes;dec appetite & tired;to MD & tx w/ rocephin & oth meds;
flu; Initial information received on 02-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who had flu , after receiving vaccine INFLUENZA VACCINE.  The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.    On an unknown date in Nov-2022, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer, with an unknown formulation and strength (lot number and expiry date: not reported)  via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious event of  flu (influenza) (latency: unknown) following the administration of INFLUENZA VACCINE.  It is unknown if there were lab data/results available  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
STARTED WITH NAUSEA AND BY THAT EVENING I HAD LOW GRADE FEVER ,CHILLS, NAUSEA, VOMITTING AND SEVERE BODY ACHES
No immediate adverse reactions to the vaccination.  Reporting this as a symptomatic positive COVID test after being fully vaccinated.
she didn't get pneumonia unless she got a pneumonia vaccine; she didn't get pneumonia unless she got a pneumonia vaccine; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose unknown, single for immunization. Medical history included bariatric surgery from 2019. The patient's concomitant medications were not reported. The patient previously took flu vaccine for Immunisation and experienced flu and she was hospitalized (She didn't get sick with the flu unless she took a flu vaccine). It was reported that the patient didn't get pneumonia unless she got a pneumonia vaccine on an unspecified date, and the patient was hospitalized. The outcome of event was unknown.  Pfizer is a marketing authorization holder of pneumococcal 13-val conj vac (dipht crm197 protein) in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of pneumococcal 13-val conj vac (dipht crm197 protein) has submitted the same report to the regulatory authorities.  Information on the lot/batch number has been requested.
pt recv vax 27MAR97 & 5MAY97 pt exp a fever, cough, & congestion;pt devel swelling around the jaw area 11MAY97;dx w/parotitis & this was considered a poss case of mumps;this was reported as vaccine failure;
Client states that 1 WEEK after his vaccination he developed a rash in a 3 inch  radius around his injection site. He states that it was warm and itchy.
4/27/2021   Pt was observed post Covid-19 immunization for 15 minutes .  During the observation period, she experienced an adverse reaction with the following symptoms:  itching to face and neck.   Assessment : Time of assessment Alert and oriented, Anxious and itching to face and neck. No rash seen by this writer   Actions taken:  Vitals sign taken  VAERS form obtained and completed by RN. VS taken at 1532- BP- 129/85, P- 73, O2- 100%, Water given.       Medications administered: Loratadine (Claritin) 10 mg  by mouth. Time: 1532. Administered by RN. Famotidine (Pepcid) 20 mg by mouth. Time: 1532. Administered by RN.   Disposition: Reports no further symptoms of adverse reaction after observation for 40 minutes. Discharged home. Instructed to call 911 for trouble breathing, rapid heart rate, dizziness, swelling of tongue or throat. The Patient was provided with Vaccine Information Sheet and instruction to access the CDC system.      Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 4/27/2021  3:13 PM
Next day, 11/20/2020, arm swelling and redness at site of injection. Redness has continued down arm towards right elbow. Extreme itching. Rubbing alcohol applied to skin to avoid itching.
Two weeks after vaccine, I started experiencing severe insomnia which has lasted a little more than two weeks now. I feel tightness in my chest. I'm beginning to clear up some congestion in my throat which I felt might have been in my lungs earlier. The insomnia sometimes feels like maybe I'm not breathing deep enough. Sometimes, I fall asleep for a few minutes and wake up extremely restless.
rash has more than 6 episodes; This spontaneous case was reported by a physician and describes the occurrence of RASH (rash has more than 6 episodes) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash has more than 6 episodes). At the time of the report, RASH (rash has more than 6 episodes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
HYPOTENSION 3/22/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Severe redness, swelling, heat after IPV, Dtap, LUE extending to below elbow. RX. Benadryl.
10days post #2 jab, developed a productive cough and  malaise.  Productive sputum is clear and thick. Cough wakes me up at night. Using albuterol inhailer .
Family came in to be vaccinated for flu during a flu clinic. signed consents and administered.  Upon updating system records, was noted that patient received flu vaccine from clinic on 9/12/2022
Information has been received from a pharmacist concerning a 67 years old patient of unknown gender. The patient's pertinent medical history and concurrent conditions were not informed. On 14-OCT-2016 the patient was vaccinated with ZOSTAVAX 19400 PFU, lot # M032360, expiration date 18-AUG-2017, 0.65 ml administered once per subcutaneous route due a patient request. On the same date, the patient was vaccinated with a dose of pneumococcal vaccine (manufacturer unknown), lot # reported as N34936, expiration date October of 2017, (dosage was not provided), administered per intramuscular route. Concomitant therapies were not informed. It was reported that on unspecified date in October of 2016, reported as "unspecified onset", the patient experienced an injection site reaction described as: "redness, pain and swelling" (injection site erythema, injection site pain and injection site swelling). It was also informed that the patient sought medical attention by contacting the pharmacist and he states that the patient was prescribed treatment of "take TYLENOL and apply Hydrocortisone cream to reduce swelling at the injection site". The outcome of the adverse events was reported as not recovered at the time of the report. The causality relationship between ZOSTAVAX, pneumococcal (manufacturer unknown) and the adverse events was not reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Patient stated his arm from his elbow to his shoulder was warm for 1 hour. He also stated he was achy and he had joint aches more then usual.
Received at 330pm. @4pm while at my neighbors home across the street from my house, I started to feel weak, woozy with a warm feeling coming over me. I drank some water, ate some food and felt ok. Around 7pm, I walked across the street to my house. Got in the door and felt like my head and sinuses were stuffy, foggy, fatigues as if my head was "expanding, pressure. Started up the stairs and immediately had to sit feeling really fatigued. Like I just wanted to go to bed. My mouth was dry and I felt weak like I had low blood sugar.  I managed to get to my bed and felt like my heart was coming out of my chest. I tried to deep breath, focus and I prayed. 7;15 my HR was 125-130; 7;20 HR was 110, 7:35 down to 90; 8pm to 86, then 8:14 78. A friend texted me and I asked them to come over until I started to feel better. At 8:37 pm I was able to get down stair and my HR was 90-76, but my head felt stuffy and clogged.
Enlarged lymph nodes under left arm (front of armpit). Very tender in both armpits, on sides of breasts.
Stomach bothered her; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach bothered her) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Stomach bothered her). At the time of the report, ABDOMINAL DISCOMFORT (Stomach bothered her) had resolved.            Concomitant product use was not provided.   Treatment information was not  provided.  Patient drank water and the issue was resolved.
This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she got the Shingles vaccine and a week later got shingles. The patient stated he/she still dealing with lots of complications. The follow-up would not possible as no contact details were available.
Rec'd vaccine approx 1400 on 9/11. Woke up with severe (L) sided neck and upper back pain which moved into (L) arm (injection site on (L)). Pain has lasted 73 days; very slow to resolve.
Information has been received from a health professional concerning a 44 month old white female with no known history or drug allergies who on 04/14/2003 was vaccinated subcutaneously in the left thigh with a first dose of varicella virus vaccine live (Oka/Merck) (Lot #644565/1149M). Concomitant vaccination the same day included a first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistra RA 27/3) (MSD) (lot #644644/1080M) given SC in the left thigh. On 12/11/2005, the patient developed 3 to 4 spots and on 12/12/2005 she had approximately 18 lesions. Some of the lesions were blistering and scabbed over and some were itchy. The patient's mom treated her with home care over the counter products. Subsequently she recovered. Additional information has been requested.
Narrative: COVID infection following COVID vaccine series 01/18, Pfizer, dose #1 02/09, Pfizer, dose #2 02/16 PCR COVID 19 result: no detected 02/16 PCR FLU A result: negative 02/16 PCR FLU B result: negative 02/16 PCR RSV result: negative 05/30 08/23 COVID swab, result: NOT detected 08/06 pt cc: exposure: unknown 08/06 08/23 COVID swab, result: detected 08/06 CXR impression: No acute cardiopulmonary abnormality or change since 02/16/2021. 08/6-08/19 pt admitted to medicine from ED dx: covid pna & HRF 08/07 ESR result: 8 08/07 Fibrinogen result: 422 08/07 DDMINER result: 0.33 08/09 DDMINER result: 0.25 08/10 DDIMER result: 0.25 08/12 SAR-COV-2 Variant testing result: pending 08/14 Procalcitonin result: <0.05 08/14 CXR impression: No acute cardiopulmonary disease. 08/17 ESR result: 48 08/17 Fibrinogen result: 515 08/17 DDIMER result: 10.45 08/19 COVID swab, result: detected 08/18 ESR result: 37 08/18 Fibrinogen result: 491 08/18 DDIMER result: 1.15 08/19 ESR 53 08/20 pt was admitted to SNF 08/23 COVID swab, result: detected 08/23 CXR impression: Mild diffuse patchy opacities within lungs bilaterally, greatest in lower lungs. Findings are new/increased since the prior study. 08/27 clinically resolved
Patient stated at the time of vaccine administered, " it felt like ice in my arm". Patient stated that she rubbed the site all the way home. Experience increased blood pressure  shortly there after. Recorded a BP read of 176/76  on 10/23/2022. Patient also states large red whelp to injection site. Patient also stated that on Tuesday 10/25/2022 that the color of the injection site has turned yellow and she believes to be a deep bruise. Patient saw heath care provider on 10/24/2022 for elevated blood pressure only. Blood pressure at the time of visit on 10/24/2022 was 151/77.
Patient stated that the injection site turned red, swelled up, and itched after receiving the vaccination.  She reported putting ice on the injection site. She returned to the pharmacy two days after receiving the vaccination and reported the reaction.  The swelling had gone down and the arm was only slightly pink, but she was still experiencing itching at the site.  I notified her primary care physician and advised the patient she should avoid further flu vaccinations.
reported left arm "tingling" on exit of a parking lot after having waited 30 mins (observation lot)- asked to be seen by medical.  "nervous" anxious" " involved in 911 and anthrax- had to take meds and this brought me back"   Given emotional support.  mask removed - fresh air.  additional wait time - 25 mins. monitoring.  Drove off lot when calm & felt able.
Headache, CoughWheeze, sinus congestion, sneezing, mild SOB. Narrative:
Periorbital edema; Dose 1: 30Mar2021, Dose 2: 16Apr2021 (duration between the doses is 17 days); This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in left arm on 16Apr2021 at 17:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation (inappropriate schedule of vaccine administered). Medical history included tonsil cancer from which the patient was recovering. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included atorvastatin 40mg (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in left arm on 30Mar2021 at 17:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 16:00, the patient experienced periorbital edema. The event resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the event which included treatment with methylprednisolone (MANUFACTURER UNKNOWN) 4mg. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event periorbital edema was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
tiny red bumps in her ankle and breast/little tiny red bumps on different parts of her body and turns into a rash when scratching them; tiny red bumps in her ankle and breast/little tiny red bumps on different parts of her body and turns into a rash when scratching them; This is a spontaneous report from a contactable consumer (patient). An 85-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 04Feb2021 (Lot Number: EL9262, unknown expiration; at the age of 85 years old) as dose 1, single for COVID-19 vaccination. Medical history included high cholesterol, blood pressure (abnormal), and glaucoma, all ongoing. Concomitant medications included simvastatin for high cholesterol; labetalol for blood pressure; enalapril for blood pressure; spironolactone for blood pressure; and bimatoprost (LUMIGAN) for glaucoma, all ongoing.  The patient previously took hydrochlorothiazide and it ran the sodium out of her body. The patient received the first dose on 04Feb2021, and second dose is scheduled on 26Feb2021. On 09Feb2021, the patient experienced tiny red bumps in her ankle and breast and when she scratches it, it turns into a rash. Event further described as little tiny red bumps on different parts of her body and turns into a rash when scratching them. Asking if it is safe for her to get the second dose of the vaccine. She has heard the second one is worse than the first, but she does not know. The patient has not yet recovered from the events.  No follow-up attempts are possible; information about batch number was already obtained.
second dose more than 42 days after first; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose more than 42 days after first) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose more than 42 days after first). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose more than 42 days after first) outcome was unknown. Not Provided          Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow-up information received on 01 JUN  2021 contain No New  Information
mom reports rxn started approx 3hr p/vax;started w/low grade fever, fine red rash on face & diaper area which spread to entire body;T102.8 R; also choked on water & formula;DPH & hydrocortisone cream 1% & amoxicillin given;
Headache, shoulder, neck ache, malaise, throat red and swollen, uvula swollen, difficulty breathing and swallowing, head stopped up, runny nose.
Information has been received from a physician concerning a child who was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). "Last week", on approximately 27-APR-2006 the patient experienced mumps and was seen by a physician. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
pt recv vax & w/in 10 days of vax pt devel h/a, muscle pain, visual distrubance & numbness in legs;pt hosp x 4 days w/dx encephalomyelitis/immune complex rxn;exp d, 5lb weight loss, arthritis-type pain, dizziness, arthralgia;
complained of difficulty breathing, headache, swollen Right hand with red rash between thumb & index finger, and slightly sore throat twenty-four hours after Typhoid vaccine
Initial misuse report received from a healthcare professional on 04 September 2013. This case is invalid as no information regarding patient was provided. Some (No information was provided regarding the patient) had received ACTHIB: mixed with saline. No adverse event was spread. List of documents held by sender: none.
Major headache starting just few hours after the vaccine. It was difficult to sleep. Treated with Tylenol the next morning. Mild tinnitus in both ears.  It's been almost 2 weeks post 1st vaccine and the ringing/humming/ shushing is still here....luckily it isn't unbearable but noticeable where I get to easily pay attention to it. I'm not sure if I should get the 2nd shot. I read reports of people's tinnitus getting worse after the 2nd shot. The headache also keeps coming and going, a lot more often than my normal range.
at injection site- pain, bruising small swelling. treatment  warm moist packs next day some reduction of all symptoms at 48hrs.
presented with a rash the next day; This is a spontaneous report from a contactable physician from a Pfizer-sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated he had a patient who received the Pfizer-Biontech covid19 vaccine and presented with a rash the next day on an unspecified date. He stated the patient also tested positive for antibodies. The reporter was asking if the patient need the second dose. The patient underwent lab tests and procedures which included antibody test: positive on an unspecified date. The outcome of event rash was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Starting 11 days after injection (1/20) the injection site is painful, red, hot to touch, hard, and spreading.  It looks like cellulitis. Also, 1 day after receiving the vaccine (1/12)  I bent over and I had terrible pain in my abdomen and it felt like my intestines were in a knot and I saw stars.  This lasted for a few hours and has recurred a few more times since after bending.